Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page’s revision/version footer has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T08:25:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T01:32:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Removed the bibliographic citation for the NEJM article Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer from the Publications section.
    Difference
    0.1%
    Check dated 2026-04-11T21:33:10.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Website revision updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T09:01:34.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T20:44:37.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-13T12:19:24.000Z thumbnail image

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.